YKL-40 expression in abnormal invasive placenta cases

References

[1] Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203:430−9.10.1016/j.ajog.2010.09.013Search in Google Scholar PubMed

[2] Kraus FT, Redline R, Gersell DJ, Nelson DM, Dicke JM. Disorders of placental development. Placental Pathology (Atlas of Noutumor Pathology). Washington, DC: American Registry of Pathology; 2004. p. 59–68.10.55418/1881041891-04Search in Google Scholar

[3] Pridjian G, Hibbard JU, Moawad AH. Cesarean: changing the trends. Obstet Gynecol. 1991;77:195−200.10.1097/00006250-199102000-00006Search in Google Scholar PubMed

[4] Fox H. Placenta accreta, 1945–1969. Obstet Gynecol Surv. 1972;27:475–90.10.1097/00006254-197207000-00001Search in Google Scholar

[5] Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008;29:639–45.10.1016/j.placenta.2008.04.008Search in Google Scholar PubMed

[6] Bischof P, Meisser A, Campana A. Paracrine and autocrine regulators of trophoblast invasion–a review. Placenta. 2000;21(Suppl A):S55–60.10.1053/plac.2000.0521Search in Google Scholar PubMed

[7] Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365(Pt 1):119–26.10.1042/bj20020075Search in Google Scholar PubMed PubMed Central

[8] De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001;285:926–31.10.1006/bbrc.2001.5253Search in Google Scholar PubMed

[9] Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999;250:168–73.10.1006/excr.1999.4511Search in Google Scholar PubMed

[10] Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol. 2009;94:1–19.10.1007/s11060-009-9919-zSearch in Google Scholar PubMed PubMed Central

[11] Saidi A, Javerzat S, Bellahcène A, De Vos J, Bello L, Castronovo V, et al. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer. 2008;122:2187–98.10.1002/ijc.23313Search in Google Scholar PubMed

[12] Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 1992;7:501–12.10.1002/jbmr.5650070506Search in Google Scholar

[13] Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev. 2006;15:194–202.10.1158/1055-9965.EPI-05-0011Search in Google Scholar

[14] Liu HW, Lin YC, Chao CF, Chang SY, Sun GH. GP-83 and GP-39, two glycoproteins secreted by human epididymis are conjugated to spermatozoa during maturation. Mol Hum Reprod. 2000;6:422–8.10.1093/molehr/6.5.422Search in Google Scholar

[15] Shostak K, Labunskyy V, Dmitrenko V, Malisheva T, Shamayev M, Rozumenko V, et al, HC gp-39 gene is upregulated in glioblastomas. Cancer Lett. 2003;198:203–10.10.1016/S0304-3835(03)00310-0Search in Google Scholar

[16] Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997;177:210–4.10.1016/S0002-9378(97)70463-0Search in Google Scholar

[17] Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accreta. Obstet Gynecol. 1999;93:545–50.Search in Google Scholar

[18] Imseis HM, Murtha AP, Alexander KA, Barnett BD. Spontaneous rupture of a primigravid uterus secondary to placenta percreta. A case report. J Reprod Med. 1998;43:233–6.Search in Google Scholar

[19] Parra-Herran C, Djordjevic B. Histopathology of placenta creta: chorionic villi intrusion into myometrial vascular spaces and extravillous trophoblast proliferation are frequent and specific findings with implications on diagnosis and pathogenesis. Int J Gynecol Pathol. 2016;35:497–508.10.1097/PGP.0000000000000250Search in Google Scholar

[20] Bandeira CL, Urban Borbely A, Pulcineli Vieira Francisco R, Schultz R, Zugaib M, Bevilacqua E. Tumorigenic factor CRIPTO-1 is immunolocalized in extravillous cytotrophoblast in placenta creta. Biomed Res Int. 2014;2014:892856.10.1155/2014/892856Search in Google Scholar

[21] Moriguchi T, Gotoh V, Nishida E. Roles of the MAP kinase cascade in vertebrates. Adv Pharmacol. 1996;36:121–37.10.1016/S1054-3589(08)60579-7Search in Google Scholar

[22] Waskiewicz AJ, Cooper JA. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol. 1995;7:798–805.10.1016/0955-0674(95)80063-8Search in Google Scholar

[23] Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13:2905–27.10.1101/gad.13.22.2905Search in Google Scholar PubMed

[24] Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem. 2006;281:21082–95.10.1074/jbc.M601153200Search in Google Scholar

[25] Tanwar MK, Gilbert MR, Holland EC. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 2002;62:4364–8.Search in Google Scholar

[26] Sjogren H, Meis-Kindblom JM, Orndal C, Bergh P, Ptaszynski K, Aman P. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses. Am J Pathol. 2003;162:781–92.10.1016/S0002-9440(10)63875-8Search in Google Scholar

[27] Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223–31.10.1016/j.lungcan.2004.11.011Search in Google Scholar PubMed